Bast A, Haenen GR. Lipoic acid: a multifunctional antioxidant. Biofactors. 2003;17(1-4):207-213. PMID: 12897442 www.ncbi.nlm.nih.gov/pubmed/12897442.
Bauer JD, Capra S. Nutrition intervention improves outcomes in patients with cancer cachexia receiving chemotherapy--a pilot study. Support Care Cancer. 2005;13(4):270-274. PMID: 15583950 www.ncbi.nlm.nih.gov/pubmed/15583950.
Baur JA, Sinclair DA. Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov. 2006;5(6):493-506. PMID: 16732220 www.ncbi.nlm.nih.gov/pubmed/16732220.
Boros LG, Nichelatti M, Shoenfeld Y. Fermented wheat germ extract (Avemar) in the treatment of cancer and autoimmune diseases. Ann N Y Acad Sci. 2005;1051:529-542. PMID: 16126993 www.ncbi.nlm.nih.gov/pubmed/16126993.
Buijs Jt, van der Pluijm G. Osteotropic cancers: from primary tumor to bone. Cancer Lett. 2009;273(2):177-193. PMID: 18632203 www.ncbi.nlm.nih.gov/pubmed/18632203.
Cabrera C, Artacho R, Gimenez R. Beneficial effects of green tea--a review. J Am Coll Nutr. 2006;25(2):79-99. PMID: 16582024 www.ncbi.nlm.nih.gov/pubmed/16582024.
Dawson-Hughes B. Calcium and protein in bone health. Proc Nutr Soc. 2003;62(2):505-509. PMID: 14506898 www.ncbi.nlm.nih.gov/pubmed/14506898.
Doron S, Gorbach SL. Probiotics: their role in the treatment and prevention of disease. Expert Rev Anti Infect Ther. 2006;4(2):261-275. PMID: 16597207 www.ncbi.nlm.nih.gov/pubmed/16597207.
Doroshow J. Malignant tumors of bone, sarcomas, and other soft tissue neoplasms. In: Goldman L, Schafer AI, eds. Goldman's Cecil Medicine. 25th ed. Philadelphia, PA: Elsevier; 2016;chap 202.
Dryden GW Jr, Deaciuc I, Arteel G, McClain CJ. Clinical implications of oxidative stress and antioxidant therapy. Curr Gastroenterol Rep. 2005;7(4):308-316. PMID: 16042916 www.ncbi.nlm.nih.gov/pubmed/16042916.
Dunstan CR, Felsenberg D, Seibel MJ. Therapy insight: the risks and benefits of bisphosphonates for the treatment of tumor-induced bone disease. Nat Clin Pract Oncol. 2007;4(1):42-55. PMID: 17183355 www.ncbi.nlm.nih.gov/pubmed/17183355.
Goggs R, Vaughan-Thomas A, Clegg PD, et al. Nutraceutical therapies for degenerative joint diseases: a critical review. Crit Rev Food Sci Nutr. 2005;45(3):145-164. PMID: 16048146 www.ncbi.nlm.nih.gov/pubmed/16048146.
Goldman L, Schafer AI, eds. Goldman's Cecil Medicine. 25th ed. Philadelphia, PA: Elsevier; 2016.
Henry DH, Costa L, Goldwasser F, et al. Randomized, double-blind study of denosumab versus zoledronic acid in the treatment of bone metastases in patients with advanced cancer (excluding breast and prostate cancer) or multiple myeloma. J Clin Oncol. 2011; 29(9):1125-1132. PMID: 21343556 www.ncbi.nlm.nih.gov/pubmed/21343556.
Hicks RJ, Ware RE, Lau EW. PET/CT: will it change the way that we use CT in cancer imaging? Cancer Imaging. 2006;6:S52-S62. PMID: 17114079 www.ncbi.nlm.nih.gov/pubmed/17114079.
Kelemen LE, Cerhan JR, Lim U, et al. Vegetables, fruit, and antioxidant-related nutrients and risk of non-Hodgkin lymphoma: a National Cancer Institute-Surveillance, Epidemiology, and End Results population-based case-control study. Am J Clin Nutr. 2006;83(6):1401-1410. PMID: 16762953 www.ncbi.nlm.nih.gov/pubmed/16762953.
Klein A, Olendrowitz C, Schmutzler R, et al. Identification of brain- and bone-specific breast cancer metastasis genes. Cancer Lett. 2009;276(2):212-220. PMID: 19114293 www.ncbi.nlm.nih.gov/pubmed/19114293.
Labinskyy N, Csiszar A, Veress G, et al. Vascular dysfunction in aging: potential effects of resveratrol, an anti-inflammatory phytoestrogen. Curr Med Chem. 2006;13(9):989-996. PMID: 16611080 www.ncbi.nlm.nih.gov/pubmed/16611080.
Lichtenstein AH, Russell RM. Essential nutrients: food or supplements? Where should the emphasis be? JAMA. 2005;294(3):351-358. PMID: 16030280 www.ncbi.nlm.nih.gov/pubmed/16030280.
Mackiewicz-Wysocka M, Pankowska M, Wysocki PJ. Progress in the treatment of bone metastases in cancer patients. Expert Opin Investig Drugs. 2012;21(6):785-795. PMID: 22500564 www.ncbi.nlm.nih.gov/pubmed/22500564.
MacLean CH, Newberry SJ, Mojica WA, et al. Effects of omega-3 fatty acids on cancer risk: a systematic review. JAMA. 2006;295(4):403-415. Review. PMID: 16434631 www.ncbi.nlm.nih.gov/pubmed/16434631.
Mantyh P. Bone cancer pain: causes, consequences, and therapeutic opportunities. Pain. 2013;154 Suppl 1:S54-S62. PMID: 23916671 www.ncbi.nlm.nih.gov/pubmed/23916671.
Montiel-Ruiz RM, Acosta-Gonzalez RI, Jimenez Andrade JM. Bone cancer pain: from preclinical pharmacology to clinical trials. Gac Med Mex. 2013;149(2):204-211. PMID: 23652187 www.ncbi.nlm.nih.gov/pubmed/23652187.
Simopoulos AP. Omega-3 fatty acids in inflammation and autoimmune diseases. J Am Coll Nutr. 2002;21(6):495-505. PMID: 12480795 www.ncbi.nlm.nih.gov/pubmed/12480795.
Tsuya A, Fukuoka M. Bone metastases in lung cancer. Clin Calcium. 2008;18(4):455-459. PMID: 18379026 www.ncbi.nlm.nih.gov/pubmed/18379026.
Usui T. Pharmaceutical prospects of phytoestrogens. Endocr J. 2006;53(1):7-20. PMID: 16543667 www.ncbi.nlm.nih.gov/pubmed/16543667.
Yoon JH, Baek SJ. Molecular targets of dietary polyphenols with anti-inflammatory properties. Yonsei Med J. 2005;46(5):585-596. PMID: 16259055 www.ncbi.nlm.nih.gov/pubmed/16259055.